Truist reiterates Buy on Klaviyo stock ahead of quarterly results By Investing.com

Truist reiterated a Buy on Klaviyo with a $35 price target, implying more than 50% upside from the current $22.76 share price. The firm expects strong first-quarter fiscal 2026 results and raised guidance, while trimming gross margin assumptions due to greater adoption of lower-margin mobile messaging products. The article also highlighted recent product updates, including Custom Skills for the AI Customer Agent and a deeper Canva integration, reinforcing the company’s platform expansion.

Analysis

KVYO is still in the classic “good business, compressing multiple” phase: the market is rewarding durability of growth, but it is not yet paying up for the operating leverage that should emerge once new products scale. The key second-order effect is that lower-margin mobile messaging can act as a near-term gross margin drag while simultaneously increasing platform stickiness, which tends to reduce churn and expand wallet share over a 12-24 month horizon. That means the stock is likely to react more to guidance credibility than to the headline gross margin print.

The biggest setup into earnings is not just beat-or-miss, but whether management can frame AI/customer-service and messaging adoption as a mix shift with a clear path to margin normalization. If they can show that opex discipline is offsetting product-mix pressure without slowing growth, the market should re-rate the name as a durable compounder rather than a single-product marketing tool. Conversely, if international or multi-product expansion comes with heavier sales intensity, the current optimism can unwind quickly because the valuation already implies a clean expansion story.

The contrarian view is that consensus may be underestimating how much of the upside is already in the stock after the recent wave of analyst upgrades. At the same time, downside is likely capped unless guidance disappoints materially, because the company’s growth profile gives it optionality on a 12-month basis. The risk/reward is asymmetric, but the path will probably be noisy: the next 1-2 quarters matter more for narrative than for intrinsic value, which is still being built through customer engagement expansion and product layering.

A secondary implication for Morgan Stanley is minimal in fundamental terms, but if resumption of coverage proves sticky, it can help keep the name in the “approved institutional growth basket,” supporting flows on dips. The main catalyst stack is earnings, forward guidance, and commentary on attach rates for newer products; those are the variables that can either validate the premium or force a de-rating if growth quality appears to be deteriorating.

Key Decisions for Investors

• Go long KVYO into earnings only on a pullback toward the low-$20s; use a 4-8 week horizon and target a move back to the high-$20s if guidance confirms operating leverage. Risk: a guide-down or slower new-product adoption can compress the multiple back into the high teens.
• For higher convexity, buy KVYO call spreads in the next 1-2 expiries rather than stock; the setup is a catalyst-driven re-rating, and options limit damage if margin mix commentary disappoints. Prefer strikes just above the consensus target zone to avoid overpaying for upside already crowded into sell-side models.
• Pair trade: long KVYO / short a lower-quality SaaS basket with weaker net retention and no AI/product expansion narrative over the next quarter. The thesis is that capital should continue rotating toward names with visible cross-sell and platform expansion, while weaker peers de-rate on slower growth durability.
• If KVYO gaps up sharply on earnings, take partial profits into the move rather than chase; the stock’s near-term upside is more sensitive to guidance than to a one-quarter beat. Re-enter only if management increases full-year confidence without a corresponding spike in CAC or opex.